Regenerative Medicine · Miami, FL
MUSE Cell Therapy in Miami
Karli Health is led by Harvard-trained physician, researcher and published author David Karli, MD, MBA.
MUSE cells, short for multilineage-differentiating stress-enduring cells, are a specialized stem cell population being studied for their ability to withstand cellular stress, respond to injury signals, migrate toward damaged tissue and support tissue repair. At Karli Health, MUSE cell therapy is physician-led, the viable cell dose is measured immediately before treatment, and outcomes are tracked through the Greyledge Data Cloud.
The Therapy
What Are MUSE Cells?
MUSE cells, or multilineage-differentiating stress-enduring cells, are a small, specialized population found within mesenchymal stem/stromal cells. “Multilineage-differentiating” means they can develop into multiple specialized cell types, while “stress-enduring” means they can survive and remain functional under cellular stress.
A simple way to think about MUSE cells is as a cellular version of “survival of the fittest,” a smaller population able to withstand harsh conditions that many other cells cannot.
Researchers are also studying their ability to respond to injury signals, migrate or “home” toward damaged tissue, self-renew, and support tissue-repair communication.
Umbilical Cord Cell Therapy
Allogeneic
Ethically sourced donor cells used under Florida law, with full sourcing and screening standards.
Explore Umbilical Cord Cell Therapy
Exosome Therapy
Cell-Derived
Cell-derived signaling vesicles, evaluated for sourcing, safety and evidence.
Learn More About Peptide TherapyWhy MUSE Cells Are Getting Attention
MUSE cells are gaining attention because they combine several characteristics researchers consider important in regenerative medicine, including stress resistance, response to injury signals, migration or “homing” toward damaged tissue, self-renewal, anti-inflammatory and immunomodulatory effects, and the ability to develop into multiple specialized cell types.
Research has now moved beyond laboratory and animal models into human clinical studies. Some findings are encouraging, but human studies remain limited and the science is still developing.
At Karli Health, we see real promise in how MUSE cells function, but promise is not proof. That is why the Karli Standard is built around measuring what is administered, tracking patient outcomes, and refining treatment protocols as the science and our own data continue to grow.
How Are MUSE Cells Different From Umbilical Cord-Derived Cells?
MUSE cells and umbilical cord-derived cells are both donor-derived regenerative cell therapies, but they are not the same. MUSE cells represent a smaller, specialized population found within mesenchymal cell populations, while umbilical cord-derived therapy generally uses a broader population of mesenchymal stem/stromal cells sourced from Wharton’s jelly.
The biological difference is important. MUSE cells are unusually resistant to cellular stress and are being studied for their ability to recognize injury-related signals, migrate or “home” toward damaged tissue, self-renew, and differentiate into specialized cells from all three germ layers. One pathway involved in this injury-directed homing is the S1P–S1PR2 signaling system.
Umbilical cord-derived mesenchymal cells are also studied for regenerative signaling, including anti-inflammatory and immunomodulatory activity. Their effects are thought to rely heavily on the signals and factors they release to influence the surrounding tissue environment.
A simple way to think about the difference is that MUSE therapy focuses on a smaller, more specialized cell population with distinct stress-enduring and injury-responsive characteristics, while umbilical cord-derived therapy uses a broader mesenchymal cell population. Neither is automatically “better.”
At Karli Health, donor-cell options are evaluated based on the patient’s diagnosis, medical history, treatment goals, available evidence, safety considerations, and physician assessment.
How Does Karli Health Approach MUSE Cell Therapy?
Karli Health is not a trend-driven clinic. We believe in advancing regenerative medicine and pushing the boundaries of what may be possible, but never at the expense of patient safety, scientific discipline, or appropriate medical evaluation.
Because MUSE cell therapy is still emerging, Dr. Karli and the Karli Health team measure the viable cell dose administered, document the route of administration, and track patient-reported outcomes over time through the Greyledge Data Cloud.
That data allows the team to evaluate patterns, better understand dose-response relationships, and continue refining how, when, and for whom MUSE cell therapy may be most appropriately considered.
The Karli Standard remains the same: measure, treat, track, refine.
What Conditions May Be Evaluated for MUSE Cell Therapy?
Depending on diagnosis, medical history, imaging and physician evaluation, MUSE cell therapy may be considered for qualifying orthopedic, wound care and pain-management conditions under Florida law.
Explore Orthopedic Care
Florida Law and Donor Cell Therapy
Florida law permits licensed physicians to perform certain non-FDA-approved stem cell therapies when the treatment is within the physician’s scope of practice and is related to orthopedics, wound care, or pain management.
At Karli Health, MUSE cell therapy is considered only within those guidelines and after appropriate physician evaluation, informed consent, safety review, and product documentation
Florida authorization does not mean that MUSE cell therapy is FDA-approved.
Safety, Sourcing, and Screening
Karli Health works directly with the company that manufactures and distributes the Dezawa MuseCells® used in our practice. Product source, identity, lot-specific documentation, Certificate of Analysis (COA), safety testing, and manufacturer-provided viability documentation are reviewed before treatment.
Karli Health then verifies the viable cell dose again immediately before treatment. In our on-site laboratory, cell viability is measured using a mini flow cytometer that counts living and dead cells, giving Dr. Karli an additional confirmation of the actual viable cell dose being administered.
Your treating physician also reviews the potential risks, benefits, limitations, and alternatives with you before proceeding.
Published MUSE Research Matters. So Does What We’re Learning Now.
MUSE cells have some published human clinical research, including studies in stroke, spinal cord injury and cardiovascular disease, with more research underway. Traditional trials can take months or years before results are published.
At Karli Health, the Greyledge Data Cloud, a platform where measured treatment dose, administration details and patient-reported outcomes are recorded and tracked, provides an active source of treatment and outcome data. Its data can be pulled and analyzed in real time, helping Dr. Karli use what is being learned now, not just what was published months or years ago.
As that data grows, it can help refine MUSE cell dosing, administration technique and treatment selection.
Why Real-Time Patient Data Matters When Choosing Where to Get MUSE Stem Cell Therapy
For you, this means more informed care. Karli Health measures the viable cell dose you receive, tracks what happens afterward and compares those outcomes with a growing body of regenerative-treatment data.
As more patients are tracked, the data help us better understand what appears to work, what does not, and how dose, administration and treatment selection may be refined. That gives Dr. Karli more current information to make the most informed treatment recommendation possible for the patient in front of him.
This is one of the most powerful differences at Karli Health. As the only Greyledge location in Florida, Karli Health has direct access to a sophisticated outcomes system that most regenerative medicine practices simply do not have. Its data can be pulled and analyzed in real time, with machine learning and AI-assisted analysis helping identify meaningful patterns as they emerge. For you, that means Dr. Karli can use the most current information available to explain what he recommends, why he recommends it and how your treatment is being refined.
Frequently Asked Questions
MUSE stands for multilineage-differentiating stress-enduring cells. They are a small, specialized population within mesenchymal stem/stromal cells being studied for distinct regenerative characteristics, including stress tolerance, injury-signal response, self-renewal, and tissue repair communication.
No. Both are donor-derived regenerative cell therapies, but MUSE cells are a smaller, specialized cell population, while Karli Health’s umbilical cord-derived therapy uses a broader mesenchymal cell population sourced from Wharton’s jelly.
No. Exosomes are not stem cells. They are extracellular vesicles (EVs) involved in cell-to-cell signaling.
MUSE cell therapy may be considered for qualifying orthopedic, wound care, or pain-management conditions under Florida law, depending on diagnosis, medical history, treatment goals, safety considerations, available evidence, and Dr. Karli’s physician evaluation.
No. MUSE cell therapy is not FDA-approved. However, at Karli Health, it is considered only when permitted under Florida law and after physician evaluation, informed consent and review of the potential risks, benefits, limitations and alternatives.
MUSE cell therapy generally ranges from $15,000 to $20,000 for a single IV or injection application. Final cost depends on the route of administration, your diagnosis, the treatment plan and the number of areas or locations being treated.
Related regenerative therapies
PRP Therapy
Platelet-rich plasma prepared from your own blood, measured and dosed in our on-site lab.
Open PRP TherapyBone Marrow Concentrate — BMC
Your own bone marrow cells, concentrated and characterized before treatment.
Open Bone Marrow ConcentrateUmbilical Cord Cell Therapy
Ethically sourced donor cells used under Florida law, with full sourcing and screening standards.
Open Umbilical Cord Cell TherapyLOOK. FEEL. PERFORM GREAT.
Considering MUSE Cell Therapy?
Schedule a consultation with Karli Health to learn whether MUSE cell therapy or another regenerative medicine option may be appropriate for your condition, goals, and overall health.
Medically reviewed by David Karli, MD, MBA · Harvard-trained physician, researcher and published author
Last reviewed: September 30, 2026